AnalystsFarzin HaqueFarzin Haque's Stock Forecasts
AnalystsFarzin Haque
Sectors:
Industries:
Analyst Ranking
Top 35%
#1926 out of 5550 analysts
Average Return
+57.21%
Win Rate
60%3 out of 5
Risk vs Reward
Poor
Good
Farzin Haque's 5 best and worst ratings
Farzin Haque Analyst Color
Get additional color on Farzin Haque's coverage of popular stocks
Farzin Haque's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vor Biopharma IncVOR | 1 | Strong Buy | $50.00 | +154.07% | Initiates Coverage On | 7 months ago |
Relmada Therapeutics IncRLMD | 1 | Strong Buy | $9.00 | +151.40% | Initiates Coverage On | 10 months ago |
Nuvation Bio IncNUVB | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | a year ago |
Pyxis Oncology IncPYXS | 1 | Strong Buy | $10.00 | N/A | Assumes | 2 years ago |
Vera Therapeutics IncVERA | 1 | Strong Buy | $26.00 | N/A | Upgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.